LINEAR IMMUNOGLOBULIN A BULLOUS DERMATOSIS IN A PATIENT WITH ULCERATIVE COLITIS – A RARE BUT ESTABLISHED ASSOCIATION
Abstract
The association of linear IgA bullous dermatosis (LABD) with ulcerative colitis (UC) is defined, although the etiology of this association is still unclear. We report the case of a 41 year-old female patient with UC diagnosed 6 years ago with a crisis 2 months ago, referred for pruriginous and tense bullae with 1 month of evolution. Her past medical history was relevant for gestational diabetes, reactive depression and hypertension. She was medicated with mesalazine for 1,5 years, bisoprolol, mexazolam and drospirenone/ethinyl estradiol. Cutaneous biopsy showed a bulla on the dermoepidermal junction (DEJ) and a polymorphous inflammatory dermal infiltrate. Linear immunoreactivity for IgA on the DEJ confirmed the diagnosis of LABD. Prednisolone and dapsone were initiated with good clinical response, maintained after six months of follow-up. The aetiology of this association remains unknown, being hypothesised cross-reactivity of IgA idiotype from UC with the dermoepidermal antigens. Mesalazine imputability cannot be surely ruledout as the cause of LABD in this patient.
Downloads
References
Taghipour K, Chi CC, Vincent A, Groves RW, Venning V, Wojnarowska F. The association of bullous pemphigoid with cerebrovascular disease and dementia: a case-control study. Arch Dermatol 2010;146: 1251-4.
Shipman AR, Reddy H, Wojnarowska F. Association between the subepidermal autoimmune blistering diseases linear IgA disease and the pemphigoid group and inflammatory bowel disease: two case reports and literature review. Clin Exp Dermatol. 2012; 37(5):461-8.
Zillikens D, Wever S, Roth A, Weidenthaler-Barth B, Hashimoto T, Bröcker EB. Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol. 1995; 131: 957-8.
Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux JP, et al. Incidence and distribution of subepidermal utoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol. 1995; 131: 48-52.
Paige DG, Leonard JN, Wojnarowska F, Fry L. Linear IgA disease and ulcerative colitis. Br J Dermatol.1997; 136:779-82.
Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut. 1996; 39:690-7.
Leonard JN, Haffenden GP. Ring NP, McMinn RM, Sidgwick A, Mowbray JF, et al Linear IgA disease in adults. Br J Dermatol. 1982; 107: 301-16.
Collier PM, Wojnarowska F, Bhogal B. Class I and class II HLA antigens in chronic bullous dermatosis of childhood. Br J Dermatol. 1991; 125: 486.
Collier PM, Wojnarowska F. MHC class I and II antigens in linear IgA dermatosis. J Invest Dermatol. 1992; 98: 526.
Toyoda H, Wang SJ, Yang H-Y, Redford A, Magalong D, Tyan D, et al Distinct associations of HLA class II genes with inflammatory bowel disease. Gastroenterology. 1993; 104:741-8.
Taniguchi T, Maejima H, Saito N, Katsuoka K, Haruki S. Case of linear IgA bullous dermatosis-involved ulcerative colitis. Inflamm Bowel Dis. 2009;15(9):1284-5.
Caldarola G, Annese V, Bossa F, Pellicano R. Linear IgA bullous dermatosis and ulcerative colitis treated by proctocolectomy. Eur J Dermatol. 2009; 19:651.
Yamada S, Makino T, Jinnin M, Sakai K, Fukushima S, Inoue Y, et al. Association of linear IgA bullous disease with ulcerative colitis: a case of successful treatment with infliximab. Dermatology. 2013;227(4):295-8.
Chanal J, Ingen-Housz-Oro S, Ortonne N, Duong TA, Thomas M, Valeyrie-Allanore L, et al. Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms. Br J Dermatol. 2013; 169(5):1041-8.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
Bégaud B, Evreux JC, Jouglard J, Lagier G. Imputation of the unex- pected or toxic effects of drugs. Actualization
of the method used in France. Therapie. 1985; 40:111-8.
Benahmed S, Picot M-C, Dumas F, Demoly P. Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactions. Arch Intern Med. 2005; 165:1500-5.
Fortuna G, Salas-Alanis JC, Guidetti E, Marinkovich MP. A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: a real and separate nosological entity? J Am Acad Dermatol. 2012; 66(6):988-94
Hernández N, Borrego L, Soler E, Hernández J. Sulfasalazine-induced linear immunoglobulin A bullous dermatosis with DRESS. Actas Dermosifiliogr. 2013; 104(4): 343-6.
All articles in this journal are Open Access under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).